top of page
REducing SuiCide rates amongst individUals with diabEtes
Safety and Public Health Benefits
The US Food and Drug Administration (FDA) is participating in the RESCUE Collaborative Community, recognising the public health importance of this topic. Specifically, there are a number of potential benefits in this regard, including opportunities to improve/personalize the training/onboarding process for diabetes devices to reduce the potential associated burden; standardize/harmonization of the detection process so that suicide events can be more accurately accounted for; and proactive screening and intervention with sustained involvement from HCPs and other stakeholders to reduce the likelihood of ISI and suicide.
bottom of page